awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53618653-8763B7F2-925C-44E4-9C1A-8873CBC547A4
Q53618653-8763B7F2-925C-44E4-9C1A-8873CBC547A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53618653-8763B7F2-925C-44E4-9C1A-8873CBC547A4
A randomised comparison of the novel nucleoside analogue sapacitabine with low-dose cytarabine in older patients with acute myeloid leukaemia.
P2860
Q53618653-8763B7F2-925C-44E4-9C1A-8873CBC547A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53618653-8763B7F2-925C-44E4-9C1A-8873CBC547A4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eec5a6de7cde0cf85d172c936ae06b6feff9b761
P2860
Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells